Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 870.43B, Eli Lilly(LLY) trades at $921.00. The stock has a price-to-earnings ratio of 40.39 and currently yields dividends of 67.2%.
During the trading session on 2026-04-20, Eli Lilly(LLY) shares reached a daily high of $929.64 and a low of $912.50. At a current price of $921.00, the stock is +0.9% higher than the low and still -0.9% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.92M, versus its average volume of 2.55M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Eli Lilly (NYSE:LLY) has agreed to acquire Kelonia Therapeutics in a transaction valued at up to $7b. The deal expands Eli Lilly's presence in in vivo CAR T ce...
Eli Lilly is making a bold move, agreeing to acquire Kelonia Therapeutics in a deal worth up to $7 billion, with billions tied to future milestones and a plans....
Technology Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others Licensing Eli Lilly (LLY) said Monday it will spend up to $7 billion to buy priva...
Analyst ratings
83%
of 35 ratingsMore LLY News
Eli Lilly (LLY) is acquiring Boston-based Kelonia Therapeutics in a blockbuster $7 billion deal. Unlock hedge fund-level data and powerful investing tools for...
Eli Lilly (LLY) and Kelonia Therapeutics announced a definitive agreement for Lilly to acquire Kelonia. Under the terms of the agreement, Lilly will acquire Kel...
Eli Lilly (LLY) stock was a hot topic on Monday after the pharmaceutical company announced its acquisition of clinical-stage biotechnology company Kelonia Thera...
(RTTNews) - Eli Lilly and Company (LLY), a biotech company, Monday announced that it has agreed to acquire Kelonia Therapeutics, Inc. a clinical biotechnology c...
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, an...
Biotech and Pharma Eli Lilly Closes in on a $2 Billion Deal. What It Means for the Stock. In this article LLY Eli Lilly's deal for Kelonia Therapeutics could co...
(RTTNews) - Eli Lilly (LLY) is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, according to the Wall Street Journal, citing people f...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.